Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Pfizer Venture Investments led a $15.5 million financing round for Nodality, a South San Francisco-based biotech firm developing personalized tests for cancer and autoimmune diseases. Laboratory Corp. of America, Kleiner Perkins Caufield & Byers, TPG Biotech, and Maverick Capital also participated in the round. Nodality was founded on flow cytometry technology devised by Stanford University professor Garry Nolan. The company is developing tests to help doctors determine which treatment is best suited for a particular patient. Its first product is aimed at people with acute myelogenous leukemia.
This article has been sent to the following recipient: